Thinly traded micro cap BioLife Solutions (BLFS +17.5%) is up on average volume following its Q3 report. Highlights:
Revenue was up 79% to $5.3M, product sales were up 80% to $2.9M.
15 new customers closed in the regenerative medicine segment.
Net income jumped almost four-fold to $1.2M.
2018 guidance: Biopreservation media sales: $19M – 20M (unch); positive GAAP net income.
Previously: BioLife Solutions beats by $0.01, beats on revenue (Nov. 8)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.